Xylitol – a sweetener fights cancer

Dr. Weeks’ Comment: Xylitol fights cancer and is a safe and beneficial sweetener – it also lowers blood sugar!

SOURCE https://link.springer.com/article/10.1007/s10529-014-1757-1

Biotechnology Letters May 2015, Volume 37, Issue 5, pp 983–990|

Xylitol induces cell death in lung cancer A549 cells by autophagy


Xylitol is a widely used anti-caries agent that has anti-inflammatory effects. We have evaluated the potential of xylitol in cancer treatment. It’s effects on cell proliferation and cytotoxicity were measured by MTT assay and LDH assay. Cell morphology and autophagy were examined by immunostaining and immunoblotting. Xylitol inhibited cell proliferation in a dose-dependent manner in these cancer cells: A549, Caki, NCI-H23, HCT-15, HL-60, K562, and SK MEL-2. The IC50 of xylitol in human gingival fibroblast cells was higher than in cancer cells, indicating that it is more specific for cancer cells. Moreover, xylitol induced autophagy in A549 cells that was inhibited by 3-methyladenine, an autophagy inhibitor. These results indicate that xylitol has potential in therapy against lung cancer by inhibiting cell proliferation and inducing autophagy of A549 cells.

  1. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545CrossRefPubMedGoogle Scholar
  2. Borm PJ, Driscoll K (1996) Particles, inflammation and respiratory tract carcinogenesis. Toxicol Lett 88:109–113PubMedGoogle Scholar
  3. Brown ER, Charles KA, Hoare SA, Rye RL, Jodrell DI, Aird RE, Vora R, Prabhakar U, Nakada M, Corringham RE, DeWitte M, Sturgeon C, Propper D, Balkwill FR, Smyth JF (2008) A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer. Ann Oncol 19:1340–1346CrossRefPubMedGoogle Scholar
  4. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867CrossRefPubMedCentralPubMedGoogle Scholar
  5. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J (2000) Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 14:145–153CrossRefPubMedGoogle Scholar
  6. Fu L, Kim YA, Wang X, Wu X, Yue P, Lonial S, Khuri FR, Sun SY (2009) Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy. Cancer Res 69:8967–8976CrossRefPubMedCentralPubMedGoogle Scholar
  7. Han SJ, Jeong SY, Nam YJ, Yang KH, Lim HS, Chung J (2005) Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis. Clin Diagn Lab Immunol 12:1285–1291PubMedCentralPubMedGoogle Scholar
  8. Hippert MM, O’Toole PS, Thorburn A (2006) Autophagy in cancer: good, bad, or both? Cancer Res 66:9349–9351CrossRefPubMedGoogle Scholar
  9. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190:1375–1382CrossRefPubMedCentralPubMedGoogle Scholar
  10. Janku F, McConkey DJ, Hong DS, Kurzrock R (2011) Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 8:528–539CrossRefPubMedGoogle Scholar
  11. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori Y (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19:5720–5728CrossRefPubMedCentralPubMedGoogle Scholar
  12. Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290:1717–1721CrossRefPubMedCentralPubMedGoogle Scholar
  13. Kung CP, Budina A, Balaburski G, Bergenstock MK, Murphy M (2011) Autophagy in tumor suppression and cancer therapy. Crit Rev Eukaryot Gene Exp 21:71–100CrossRefGoogle Scholar
  14. Lynch H, Milgrom P (2003) Xylitol and dental caries: an overview for clinicians. J Calif Dent Assoc 31:205–209PubMedGoogle Scholar
  15. Moody GA, Jayanthi V, Probert CS, Mac Kay H, Mayberry JF (1996) Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 8:1179–1183CrossRefPubMedGoogle Scholar
  16. Park E, Na HS, Kim SM, Wallet S, Cha S, Chung J (2014) Xylitol, an anti-caries agent, exhibits potent inhibition of inflammatory responses in human THP-1-derived macrophages infected with Porphyromonas gingivalis. J Periodontol 85:e212–e223CrossRefPubMedGoogle Scholar
  17. Philip M, Rowley DA, Schreiber H (2004) Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14:433–439CrossRefPubMedGoogle Scholar

Leave a Comment

Your email address will not be published. Required fields are marked *